Search
Diabetes News
Home

FDA Permits Marketing of First System of Mobile Medical Apps for Continuous Glucose Monitoring

Posted by dlife on Tue, Jan 27, 15, 10:25 AM 0 Comment

January 27, 2015 (FDA) - The U.S. Food and Drug Administration today allowed marketing of the first set of mobile medical apps that allow people with diabetes to automatically and securely share data from a continuous glucose monitor (CGM) with other people in real-time using an Apple mobile device such as an iPhone.

The Dexcom Share Direct Secondary Displays system's data-sharing capability allows caregivers to a person with diabetes to monitor that individual's blood sugar levels remotely throu

Continue reading "FDA Permits Marketing of First System of Mobile Medical Apps for Continuous Glucose Monitoring"

Email this

Diabetic Neuropathy Predicted Using New Eye Scan

Posted by dlife on Tue, Jan 27, 15, 10:15 AM 0 Comment

January 27, 2015 (Diabetes.co.uk) - A new study finds that incipient peripheral neuropathy in patients with type 1 diabetes can be predicted by a technique called corneal confocal microscopy (CCM).

What is corneal confocal microscopy?

CCM is a clinical technique that studies the structure and nerve fibres of the cornea, using a laser-scanning corneal confocal microscope.

CCM has previously been used to assess peripheral diabetic neur

Continue reading "Diabetic Neuropathy Predicted Using New Eye Scan"

Email this

Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults

Posted by dlife on Thu, Jan 22, 15, 02:52 PM 0 Comment

January 22, 2015 (ACP) - Prolonged sedentary time was independently associated with deleterious health outcomes regardless of physical activity.

Read the study as seen in Annals of Internal Medicine here.

Continue reading "Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults"

Email this

Roux-en-Y Surgery May Reverse Insulin Therapy in Type 2 Diabetes

Posted by dlife on Thu, Jan 22, 15, 12:34 PM 0 Comment

January 22, 2015 (HealthDayNews) - Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes patients, independent of weight loss, according to a study published in Diabetes Care.

Ali Ardestani, MD, from Brigham and Women's Hospital in Boston, and colleagues examined changes in insulin treatment after bariatric surgery in a cohort of 5,225 patients with insulin-treated type 2 diabetes. RYGB was compared w

Continue reading "Roux-en-Y Surgery May Reverse Insulin Therapy in Type 2 Diabetes"

Email this

Liraglutide Improved Oxidative Stress, Ghrelin, Heme Oxygenase-1 Levels in Type 2 Diabetes

Posted by dlife on Thu, Jan 22, 15, 12:29 PM 0 Comment

January 22, 2015 (Healio) - In patients with type 2 diabetes, the addition of liraglutide to a metformin regimen appears to have a positive effect on oxidative stress, plasma ghrelin and heme oxygenase-1 levels, according to recent findings.

In the prospective pilot study, researchers evaluated 20 adults (10 men; mean age, 57 years) with type 2 diabetes who were assigned metformin

Continue reading "Liraglutide Improved Oxidative Stress, Ghrelin, Heme Oxygenase-1 Levels in Type 2 Diabetes"

Email this

Sign up for FREE dLife Newsletters

dLife Membership is FREE! Get exclusive access, free recipes, newsletters, savings, and much more! FPO

Congratulations!
You are subscribed!
Congratulations!
You are subscribed!
Congratulations!
You are subscribed!
Sponsor Specials

dLife Weekly Poll

How do you manage your daily meal planning?